K
Kevin L. Greason
Researcher at Mayo Clinic
Publications - 313
Citations - 15519
Kevin L. Greason is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Aortic valve replacement & Valve replacement. The author has an hindex of 42, co-authored 282 publications receiving 12650 citations. Previous affiliations of Kevin L. Greason include Shanghai Jiao Tong University & Naval Medical Center San Diego.
Papers
More filters
Journal ArticleDOI
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.
Martin B. Leon,Craig R. Smith,Michael J. Mack,Michael J. Mack,Rajendra Makkar,Lars G. Svensson,Susheel Kodali,Vinod H. Thourani,Murat Tuzcu,D. Craig Miller,Howard C. Herrmann,Darshan Doshi,David J. Cohen,Augusto D. Pichard,Samir R. Kapadia,Todd M. Dewey,Vasilis Babaliaros,Wilson Y. Szeto,Mathew R. Williams,Dean J. Kereiakes,Alan Zajarias,Kevin L. Greason,Brian Whisenant,Robert W. Hodson,Jeffrey W. Moses,Alfredo Trento,David L. Brown,William F. Fearon,Philippe Pibarot,Rebecca T. Hahn,Wael A. Jaber,William N. Anderson,Maria Alu,John G. Webb +33 more
TL;DR: In intermediate-risk patients, TAVR was similar to surgical aortic-valve replacement with respect to the primary end point of death or disabling stroke; surgery resulted in fewer major vascular complications and less paravalvular aorta regurgitation.
Journal ArticleDOI
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
Susheel Kodali,Mathew R. Williams,Craig R. Smith,Lars G. Svensson,John G. Webb,Raj Makkar,Gregory P. Fontana,Todd M. Dewey,Vinod H. Thourani,Augusto D. Pichard,Michael P. Fischbein,Wilson Y. Szeto,Scott Lim,Kevin L. Greason,Paul S. Teirstein,S. Chris Malaisrie,Pamela S. Douglas,Rebecca T. Hahn,Brian Whisenant,Alan Zajarias,Duolao Wang,Jodi J. Akin,William N. Anderson,Martin B. Leon,Trial Investigators +24 more
TL;DR: A 2-year follow-up of patients in the PARTNER trial supports TAVR as an alternative to surgery in high-risk patients, but paravalvular regurgitation was more frequent after T AVR and was associated with increased late mortality.
Journal ArticleDOI
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
Vinod H. Thourani,Susheel Kodali,Raj Makkar,Howard C. Herrmann,Mathew R. Williams,Vasilis Babaliaros,Richard W. Smalling,Scott Lim,S. Chris Malaisrie,Samir R. Kapadia,Wilson Y. Szeto,Kevin L. Greason,Dean J. Kereiakes,Gorav Ailawadi,Brian Whisenant,Chandan Devireddy,Jonathon Leipsic,Rebecca T. Hahn,Philippe Pibarot,Neil J. Weissman,Wael A. Jaber,David J. Cohen,Rakesh M. Suri,E. Murat Tuzcu,Lars G. Svensson,John G. Webb,Jeffrey W. Moses,Michael J. Mack,D. Craig Miller,Craig R. Smith,Maria Alu,Rupa Parvataneni,Ralph B. D'Agostino,Martin B. Leon +33 more
TL;DR: TAVR with SAPIEN 3 in intermediate-risk patients with severe aortic stenosis is associated with low mortality, strokes, and regurgitation at 1 year after implantation, and a significant superiority for the composite outcome with TAVR compared with surgery is indicated.
Journal ArticleDOI
Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement
Susheel Kodali,Mathew R. Williams,Craig R. Smith,Lars G. Svensson,John G. Webb,Raj Makkar,Gregory P. Fontana,Todd M. Dewey,Vinod H. Thourani,Augusto D. Pichard,Michael P. Fischbein,Wilson Y. Szeto,Scott Lim,Kevin L. Greason,Paul S. Teirstein,S. Chris Malaisrie,Pamela S. Douglas,Rebecca T. Hahn,Brian Whisenant,Alan Zajarias,Duolao Wang,Jodi J. Akin,William N. Anderson,Martin B. Leon +23 more
Journal ArticleDOI
Presentation, Diagnosis, and Outcomes of Acute Aortic Dissection: 17-Year Trends From the International Registry of Acute Aortic Dissection
Linda Pape,Mazen Awais,Elise M. Woznicki,Toru Suzuki,Santi Trimarchi,Arturo Evangelista,Truls Myrmel,Magnus Larsen,Kevin M. Harris,Kevin L. Greason,Marco Di Eusanio,Eduardo Bossone,Daniel G. Montgomery,Kim A. Eagle,Christoph A. Nienaber,Eric M. Isselbacher,Patrick T. O'Gara +16 more
TL;DR: Presenting symptoms and physical findings of AAD have not changed significantly and more patients in both groups were managed with interventional procedures: surgery in type A and endovascular therapy in type B.